Cargando…
Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416867/ https://www.ncbi.nlm.nih.gov/pubmed/34297319 http://dx.doi.org/10.1007/s40262-021-01060-8 |
| _version_ | 1783748270371110912 |
|---|---|
| author | James, Angela Joubert Smith, Catherine C. Litzow, Mark Perl, Alexander E. Altman, Jessica K. Shepard, Dale Kadokura, Takeshi Souda, Kinya Patton, Melanie Lu, Zheng Liu, Chaofeng Moy, Selina Levis, Mark J. Bahceci, Erkut |
| author_facet | James, Angela Joubert Smith, Catherine C. Litzow, Mark Perl, Alexander E. Altman, Jessica K. Shepard, Dale Kadokura, Takeshi Souda, Kinya Patton, Melanie Lu, Zheng Liu, Chaofeng Moy, Selina Levis, Mark J. Bahceci, Erkut |
| author_sort | James, Angela Joubert |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8416867 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84168672021-09-22 Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor James, Angela Joubert Smith, Catherine C. Litzow, Mark Perl, Alexander E. Altman, Jessica K. Shepard, Dale Kadokura, Takeshi Souda, Kinya Patton, Melanie Lu, Zheng Liu, Chaofeng Moy, Selina Levis, Mark J. Bahceci, Erkut Clin Pharmacokinet Correction Springer International Publishing 2021-07-23 2021 /pmc/articles/PMC8416867/ /pubmed/34297319 http://dx.doi.org/10.1007/s40262-021-01060-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction James, Angela Joubert Smith, Catherine C. Litzow, Mark Perl, Alexander E. Altman, Jessica K. Shepard, Dale Kadokura, Takeshi Souda, Kinya Patton, Melanie Lu, Zheng Liu, Chaofeng Moy, Selina Levis, Mark J. Bahceci, Erkut Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor |
| title | Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor |
| title_full | Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor |
| title_fullStr | Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor |
| title_full_unstemmed | Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor |
| title_short | Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor |
| title_sort | correction to: pharmacokinetic profile of gilteritinib: a novel flt-3 tyrosine kinase inhibitor |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416867/ https://www.ncbi.nlm.nih.gov/pubmed/34297319 http://dx.doi.org/10.1007/s40262-021-01060-8 |
| work_keys_str_mv | AT jamesangelajoubert correctiontopharmacokineticprofileofgilteritinibanovelflt3tyrosinekinaseinhibitor AT smithcatherinec correctiontopharmacokineticprofileofgilteritinibanovelflt3tyrosinekinaseinhibitor AT litzowmark correctiontopharmacokineticprofileofgilteritinibanovelflt3tyrosinekinaseinhibitor AT perlalexandere correctiontopharmacokineticprofileofgilteritinibanovelflt3tyrosinekinaseinhibitor AT altmanjessicak correctiontopharmacokineticprofileofgilteritinibanovelflt3tyrosinekinaseinhibitor AT sheparddale correctiontopharmacokineticprofileofgilteritinibanovelflt3tyrosinekinaseinhibitor AT kadokuratakeshi correctiontopharmacokineticprofileofgilteritinibanovelflt3tyrosinekinaseinhibitor AT soudakinya correctiontopharmacokineticprofileofgilteritinibanovelflt3tyrosinekinaseinhibitor AT pattonmelanie correctiontopharmacokineticprofileofgilteritinibanovelflt3tyrosinekinaseinhibitor AT luzheng correctiontopharmacokineticprofileofgilteritinibanovelflt3tyrosinekinaseinhibitor AT liuchaofeng correctiontopharmacokineticprofileofgilteritinibanovelflt3tyrosinekinaseinhibitor AT moyselina correctiontopharmacokineticprofileofgilteritinibanovelflt3tyrosinekinaseinhibitor AT levismarkj correctiontopharmacokineticprofileofgilteritinibanovelflt3tyrosinekinaseinhibitor AT bahcecierkut correctiontopharmacokineticprofileofgilteritinibanovelflt3tyrosinekinaseinhibitor |